
Metabolic Research
Semaglutide5mg
In Stock
€44.95
Retatrutide is a triple receptor agonist peptide studied at the GLP-1, GIP and glucagon receptors. This hub gathers our Retatrutide research material, certificates and product listing.

Retatrutide is a next-generation incretin research peptide investigated for simultaneous activity at three metabolic receptors.
It is supplied as a high-purity lyophilised powder with independent third-party analysis, for laboratory research use only.
Triple agonist signalling
GLP-1, GIP and glucagon receptor research.
Glucose handling
Laboratory models of glucose and insulin signalling.
Energy metabolism
Substrate use and energy expenditure research.
Comparative research
Side-by-side study against other incretin analogues.
What is Retatrutide
Sequence class, receptor targets and supply format.
In preparationRetatrutide Research
Directory of laboratory research areas for Retatrutide.
In preparationRetatrutide Clinical Trials
Overview of the published clinical trial literature.
In preparationRetatrutide Mechanism of Action
Receptor interaction and downstream signalling.
In preparationRetatrutide vs Semaglutide
How the two compounds differ in receptor coverage and research use.
In preparationRetatrutide vs Tirzepatide
Triple agonist compared with dual agonist research.
In preparationRetatrutide Half Life
Reported pharmacokinetic characteristics in the literature.
In preparationTriple Agonist Research
The wider triple agonist research landscape.
In preparation
Metabolic Research
Semaglutide5mg
In Stock
€44.95

Metabolic Research
Tirzepatide5mg
In Stock
€59.95

Metabolic Research
Cagrilintide5mg
In Stock
€49.95
References and further reading are listed within each article. Analytical documentation for the material we supply is published in our Certificates of Analysis library, and every compound in this class is listed under Metabolic Research Peptides. All products are supplied for laboratory research use only.